Faculty Articles
What Is Old Is New Again: Delafloxacin, A Modern Fluoroquinolone
ISBN or ISSN
1875-9114
Location
United States
Publication Title
Pharmacotherapy
Volume
38
Issue
1
Date of original Performance / Presentation
10-23-2017
Publication Date / Copyright Date
1-2018
First Page
108
Last Page
121
Publisher
John Wiley & Sons, Inc.
DOI Number
10.1002/phar.2050
Abstract
Delafloxacin is a new fluoroquinolone antimicrobial approved for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in adults using dosage regimens of 300 mg intravenously every 12 hours, 450 mg orally every 12 hours, or switching from intravenous to oral regimens for a 5- to 14-day treatment duration. Dosage adjustments in patients with severe renal dysfunction (estimated glomerular filtration rate [eGFR] = 15-29 ml/min/1.73 m
Disciplines
Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences
Keywords
administration, adult, anti-bacterial agents, bacterial, fluoroquinolones, gram-negative bacteria, gram-negative bacterial infections, gram-positive bacteria, gram-positive bacterial infections, humans, intravenous, oral, skin diseases
NSUWorks Citation
Cho, Jonathan C; Crotty, Matthew P; White, Bryan P; and Worley, Marylee V., "What Is Old Is New Again: Delafloxacin, A Modern Fluoroquinolone" (2018). Faculty Articles. 62.
https://nsuworks.nova.edu/hpd_corx_facarticles/62